The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
- PMID: 11520181
- DOI: 10.1006/mcne.2001.1016
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
Abstract
Nerve growth factor (NGF) is important for regulation, differentiation, and survival of peripheral and central nervous system neurons, including basal forebrain cholinergic neurons (BFCN) which degenerate in Alzheimer's disease (AD). Mature NGF protein is processed from a larger precursor, proNGF. We demonstrate that proNGF is the predominant form of NGF in mouse, rat, and human brain tissue, whereas little or no mature NGF is detected. Previous reports showed NGF protein, measured by ELISA, is increased in AD BFCN target regions such as hippocampus and cortex. Using Western blotting, we demonstrate a twofold increase in proNGF in AD parietal cortex compared to controls, indicating that it is this precursor form, proNGF, that accumulates in AD. This increase may reflect either a role for biologically active proNGF or posttranslational disturbances in NGF biosynthesis that decrease the processing of proNGF to mature NGF in AD.
Copyright 2001 Academic Press.
Similar articles
-
ProNGF, sortilin, and age-related neurodegeneration.Ann N Y Acad Sci. 2007 Nov;1119:208-15. doi: 10.1196/annals.1404.024. Ann N Y Acad Sci. 2007. PMID: 18056969 Review.
-
Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease.J Neuropathol Exp Neurol. 2009 Aug;68(8):857-69. doi: 10.1097/NEN.0b013e3181aed9e6. J Neuropathol Exp Neurol. 2009. PMID: 19606067
-
The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.J Neurochem. 2004 May;89(3):581-92. doi: 10.1111/j.1471-4159.2004.02360.x. J Neurochem. 2004. PMID: 15086515
-
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.J Neurochem. 2005 Jun;93(6):1412-21. doi: 10.1111/j.1471-4159.2005.03135.x. J Neurochem. 2005. PMID: 15935057
-
The cholinergic system, nerve growth factor and the cytoskeleton.Behav Brain Res. 2011 Aug 10;221(2):515-26. doi: 10.1016/j.bbr.2010.02.024. Epub 2010 Feb 16. Behav Brain Res. 2011. PMID: 20170684 Review.
Cited by
-
BDNF transcripts, proBDNF and proNGF, in the cortex and hippocampus throughout the life span of the rat.Age (Dordr). 2013 Dec;35(6):2057-70. doi: 10.1007/s11357-012-9495-6. Epub 2012 Dec 21. Age (Dordr). 2013. PMID: 23255148 Free PMC article.
-
Network pharmacology identify intersection genes of quercetin and Alzheimer's disease as potential therapeutic targets.Front Aging Neurosci. 2022 Aug 23;14:902092. doi: 10.3389/fnagi.2022.902092. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36081896 Free PMC article.
-
Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?Mol Neurobiol. 2005 Oct;32(2):133-44. doi: 10.1385/MN:32:2:133. Mol Neurobiol. 2005. PMID: 16215278 Review.
-
Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease.Cereb Cortex. 2020 Apr 14;30(4):2083-2098. doi: 10.1093/cercor/bhz224. Cereb Cortex. 2020. PMID: 31799623 Free PMC article.
-
proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay.Front Aging Neurosci. 2021 Oct 27;13:741414. doi: 10.3389/fnagi.2021.741414. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34776928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical